Cytochroma Initiates Phase 3 Study of CTAP101 Capsules in Chronic Kidney ... Sacramento Bee 20, 2012 -- /PRNewswire/ - Cytochroma today announced the initiation of a phase 3 study of CTAP101 capsules ("CTAP101 Capsules") in patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D ... |
